|
Nov 2
|
Arrowhead Pharmaceuticals to Present New Phase 2 Clinical Data on Cardiometabolic Pipeline at AHA 2023
|
|
Sep 11
|
Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023
|
|
Sep 9
|
10 Biotech Stocks with Biggest Upside
|
|
Sep 7
|
Is Arrowhead Pharmaceuticals (ARWR) Too Good to Be True? A Comprehensive Analysis of a ...
|
|
Aug 13
|
Swelling losses haven't held back gains for Arrowhead Pharmaceuticals (NASDAQ:ARWR) shareholders since they're up 99% over 5 years
|
|
Aug 10
|
ARWR: Enrollment Complete in PALISADE Phase 3 Trial of ARO-APOC3 in FCS...
|
|
Aug 8
|
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q3 2023 Earnings Call Transcript
|
|
Aug 8
|
Q3 2023 Arrowhead Pharmaceuticals Inc Earnings Call
|
|
Aug 8
|
15 Worst Performing Biotech Stocks in 2023
|
|
Aug 7
|
Arrowhead Pharmaceuticals Reports Fiscal 2023 Third Quarter Results
|
|
Apr 26
|
Biotech Stock Roundup: BIIB's Q1 Results, ARWR Up on Data, INCY & BLUE Offer Updates
|
|
Apr 25
|
Arrowhead Pharmaceuticals Reveals Data From Healthy Volunteers For Its Asthma Hopeful, Stock Soars
|
|
Apr 25
|
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
|
|
Apr 25
|
Arrowhead Pharmaceuticals’ Proprietary Pulmonary TRiM™ Platform Achieves High Levels of Target Gene Knockdown and Long Duration of Effect
|